| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Receptors, Nicotinic | 21 | 2016 | 497 | 1.900 |
Why?
|
| Nicotinic Agonists | 13 | 2016 | 271 | 1.300 |
Why?
|
| Behavior, Animal | 18 | 2022 | 1881 | 0.940 |
Why?
|
| Motor Activity | 13 | 2019 | 2715 | 0.800 |
Why?
|
| Antidepressive Agents | 12 | 2016 | 2838 | 0.760 |
Why?
|
| Azetidines | 6 | 2014 | 142 | 0.720 |
Why?
|
| Nicotine | 8 | 2008 | 681 | 0.550 |
Why?
|
| Neurotransmitter Uptake Inhibitors | 2 | 2010 | 37 | 0.470 |
Why?
|
| Amitriptyline | 2 | 2004 | 110 | 0.470 |
Why?
|
| Rodentia | 1 | 2014 | 261 | 0.450 |
Why?
|
| Quinoxalines | 2 | 2011 | 290 | 0.420 |
Why?
|
| Antidepressive Agents, Tricyclic | 2 | 2004 | 434 | 0.410 |
Why?
|
| Benzazepines | 2 | 2011 | 326 | 0.410 |
Why?
|
| Glycogen Synthase Kinase 3 | 2 | 2011 | 430 | 0.400 |
Why?
|
| CLOCK Proteins | 1 | 2011 | 88 | 0.390 |
Why?
|
| Fear | 10 | 2015 | 1440 | 0.390 |
Why?
|
| Iron Radioisotopes | 2 | 2021 | 21 | 0.390 |
Why?
|
| Helplessness, Learned | 4 | 2004 | 28 | 0.340 |
Why?
|
| Cyclopropanes | 3 | 2017 | 416 | 0.330 |
Why?
|
| Pyridines | 5 | 2011 | 2825 | 0.330 |
Why?
|
| Alzheimer Disease | 8 | 2023 | 8038 | 0.330 |
Why?
|
| Locomotion | 1 | 2010 | 378 | 0.310 |
Why?
|
| Alzheimer Vaccines | 2 | 2020 | 25 | 0.310 |
Why?
|
| Mice, Inbred C57BL | 23 | 2023 | 21833 | 0.310 |
Why?
|
| Presenilin-1 | 3 | 2021 | 635 | 0.310 |
Why?
|
| Sex Characteristics | 5 | 2021 | 2585 | 0.300 |
Why?
|
| Hippocampus | 7 | 2023 | 3675 | 0.290 |
Why?
|
| Swimming | 4 | 2011 | 205 | 0.290 |
Why?
|
| Drug Discovery | 1 | 2014 | 1058 | 0.280 |
Why?
|
| Mice | 46 | 2023 | 81201 | 0.270 |
Why?
|
| Antipsychotic Agents | 4 | 2017 | 3057 | 0.270 |
Why?
|
| Animals | 65 | 2023 | 168768 | 0.260 |
Why?
|
| Anxiety | 4 | 2019 | 4293 | 0.260 |
Why?
|
| Morphine | 4 | 2001 | 657 | 0.260 |
Why?
|
| Plaque, Amyloid | 3 | 2021 | 729 | 0.250 |
Why?
|
| Complement C3 | 2 | 2017 | 461 | 0.240 |
Why?
|
| Mice, Knockout | 20 | 2022 | 14561 | 0.240 |
Why?
|
| Serotonin 5-HT2 Receptor Agonists | 2 | 2017 | 31 | 0.240 |
Why?
|
| Benzhydryl Compounds | 1 | 2010 | 845 | 0.230 |
Why?
|
| Disease Models, Animal | 9 | 2021 | 18034 | 0.230 |
Why?
|
| Pyrrolidonecarboxylic Acid | 3 | 2021 | 65 | 0.230 |
Why?
|
| Hindlimb Suspension | 4 | 2010 | 83 | 0.220 |
Why?
|
| Wakefulness | 1 | 2010 | 1245 | 0.220 |
Why?
|
| Methylamines | 2 | 2017 | 123 | 0.220 |
Why?
|
| Central Nervous System Stimulants | 2 | 2010 | 1148 | 0.210 |
Why?
|
| Piperidines | 1 | 2010 | 1602 | 0.210 |
Why?
|
| Islet Amyloid Polypeptide | 1 | 2021 | 41 | 0.210 |
Why?
|
| Structure-Activity Relationship | 9 | 2017 | 3130 | 0.210 |
Why?
|
| Cocaine | 4 | 2010 | 1007 | 0.200 |
Why?
|
| alpha-Synuclein | 2 | 2018 | 722 | 0.200 |
Why?
|
| Conditioning, Classical | 5 | 2005 | 366 | 0.200 |
Why?
|
| RGS Proteins | 2 | 2013 | 77 | 0.190 |
Why?
|
| Gamma Rays | 1 | 2021 | 320 | 0.190 |
Why?
|
| Amyloid beta-Peptides | 5 | 2023 | 3587 | 0.190 |
Why?
|
| Dose-Response Relationship, Drug | 6 | 2011 | 10943 | 0.180 |
Why?
|
| Isoxazoles | 2 | 2012 | 216 | 0.180 |
Why?
|
| Dementia, Vascular | 1 | 2021 | 129 | 0.180 |
Why?
|
| Nicotinic Antagonists | 4 | 2014 | 96 | 0.180 |
Why?
|
| tau Proteins | 3 | 2021 | 1868 | 0.170 |
Why?
|
| Socialization | 1 | 2019 | 87 | 0.170 |
Why?
|
| Mice, Inbred BALB C | 7 | 2019 | 6386 | 0.170 |
Why?
|
| Drug Partial Agonism | 4 | 2012 | 24 | 0.170 |
Why?
|
| Anti-Anxiety Agents | 1 | 2021 | 390 | 0.170 |
Why?
|
| Ligands | 7 | 2017 | 3282 | 0.160 |
Why?
|
| Brain Chemistry | 1 | 2002 | 982 | 0.160 |
Why?
|
| Electroshock | 7 | 2005 | 122 | 0.160 |
Why?
|
| Freezing Reaction, Cataleptic | 2 | 2016 | 42 | 0.160 |
Why?
|
| Rats, Sprague-Dawley | 11 | 2010 | 8300 | 0.160 |
Why?
|
| Urination | 1 | 2019 | 204 | 0.160 |
Why?
|
| Rats | 16 | 2021 | 24252 | 0.160 |
Why?
|
| Physical Conditioning, Animal | 1 | 2021 | 354 | 0.150 |
Why?
|
| Association Learning | 3 | 2006 | 224 | 0.150 |
Why?
|
| Fibronectins | 1 | 2021 | 726 | 0.150 |
Why?
|
| Larva | 2 | 2016 | 519 | 0.150 |
Why?
|
| Receptor, Serotonin, 5-HT2C | 1 | 2017 | 44 | 0.150 |
Why?
|
| Receptors, GABA-A | 1 | 2022 | 627 | 0.150 |
Why?
|
| Mice, Transgenic | 9 | 2023 | 9735 | 0.150 |
Why?
|
| Reflex | 1 | 2019 | 365 | 0.150 |
Why?
|
| Hormones | 1 | 2021 | 889 | 0.150 |
Why?
|
| Neurons | 7 | 2018 | 9340 | 0.150 |
Why?
|
| Immunization, Passive | 2 | 2020 | 623 | 0.150 |
Why?
|
| Space Flight | 1 | 2019 | 188 | 0.150 |
Why?
|
| Seizures | 2 | 2022 | 2859 | 0.150 |
Why?
|
| Dopamine Uptake Inhibitors | 2 | 2010 | 312 | 0.140 |
Why?
|
| Depression | 5 | 2014 | 7759 | 0.140 |
Why?
|
| Receptors, Adrenergic, beta-2 | 1 | 2017 | 201 | 0.140 |
Why?
|
| Escape Reaction | 1 | 2016 | 54 | 0.140 |
Why?
|
| Benzylamines | 1 | 2017 | 223 | 0.140 |
Why?
|
| Bipolar Disorder | 2 | 2011 | 5027 | 0.140 |
Why?
|
| Receptors, sigma | 1 | 2016 | 28 | 0.140 |
Why?
|
| Tobacco Use Disorder | 1 | 2002 | 688 | 0.140 |
Why?
|
| Microglia | 2 | 2022 | 1267 | 0.140 |
Why?
|
| Mecamylamine | 2 | 2006 | 29 | 0.140 |
Why?
|
| Molecular Structure | 4 | 2016 | 1899 | 0.130 |
Why?
|
| Amyloid beta-Protein Precursor | 2 | 2021 | 1121 | 0.130 |
Why?
|
| Brain | 11 | 2021 | 26388 | 0.130 |
Why?
|
| Parkinsonian Disorders | 1 | 2018 | 275 | 0.130 |
Why?
|
| Antibodies, Monoclonal | 3 | 2020 | 9274 | 0.130 |
Why?
|
| Synaptosomes | 2 | 2015 | 115 | 0.130 |
Why?
|
| Neurosciences | 1 | 2019 | 348 | 0.130 |
Why?
|
| Cognition | 4 | 2021 | 6770 | 0.130 |
Why?
|
| Apyrase | 1 | 2017 | 364 | 0.120 |
Why?
|
| Stereoisomerism | 5 | 2017 | 624 | 0.120 |
Why?
|
| Zebrafish | 2 | 2016 | 2996 | 0.120 |
Why?
|
| Stress, Physiological | 1 | 2002 | 1403 | 0.120 |
Why?
|
| Maze Learning | 4 | 2015 | 478 | 0.120 |
Why?
|
| Neuroglia | 1 | 2020 | 928 | 0.120 |
Why?
|
| Pain Threshold | 3 | 1996 | 584 | 0.120 |
Why?
|
| Nerve Degeneration | 2 | 2017 | 748 | 0.120 |
Why?
|
| Dopamine | 3 | 2010 | 1591 | 0.120 |
Why?
|
| Substance-Related Disorders | 2 | 2010 | 4257 | 0.120 |
Why?
|
| Avoidance Learning | 4 | 2005 | 233 | 0.110 |
Why?
|
| Organ Transplantation | 1 | 2023 | 1140 | 0.110 |
Why?
|
| Social Behavior | 1 | 2019 | 1127 | 0.110 |
Why?
|
| Analgesia | 1 | 1997 | 461 | 0.110 |
Why?
|
| Aging | 5 | 2023 | 8664 | 0.110 |
Why?
|
| Adenosine | 1 | 2017 | 825 | 0.110 |
Why?
|
| Amygdala | 1 | 2019 | 1315 | 0.100 |
Why?
|
| Male | 37 | 2023 | 350115 | 0.100 |
Why?
|
| Adenosine Triphosphate | 1 | 2017 | 2027 | 0.100 |
Why?
|
| Analysis of Variance | 3 | 2008 | 6366 | 0.100 |
Why?
|
| Aza Compounds | 1 | 2010 | 32 | 0.090 |
Why?
|
| Mice, Inbred A | 1 | 2010 | 248 | 0.090 |
Why?
|
| Nociceptors | 1 | 1994 | 432 | 0.090 |
Why?
|
| Radioligand Assay | 4 | 2012 | 374 | 0.090 |
Why?
|
| Small Molecule Libraries | 1 | 2016 | 720 | 0.090 |
Why?
|
| Depressive Disorder | 1 | 2003 | 3747 | 0.090 |
Why?
|
| Biogenic Monoamines | 1 | 2010 | 50 | 0.090 |
Why?
|
| Mice, Mutant Strains | 2 | 2011 | 1865 | 0.090 |
Why?
|
| Dose-Response Relationship, Radiation | 2 | 2023 | 876 | 0.090 |
Why?
|
| Tranylcypromine | 1 | 2009 | 29 | 0.090 |
Why?
|
| Adrenergic Uptake Inhibitors | 1 | 2010 | 189 | 0.090 |
Why?
|
| Chromosome Mapping | 1 | 1997 | 4740 | 0.080 |
Why?
|
| Cell Proliferation | 1 | 2004 | 10483 | 0.080 |
Why?
|
| Substance Withdrawal Syndrome | 3 | 2010 | 632 | 0.080 |
Why?
|
| Time Factors | 5 | 2021 | 40075 | 0.080 |
Why?
|
| GTP-Binding Proteins | 1 | 2013 | 970 | 0.080 |
Why?
|
| Mitochondria | 1 | 2022 | 3514 | 0.080 |
Why?
|
| Pyrrolidines | 1 | 2010 | 342 | 0.080 |
Why?
|
| Transcription, Genetic | 2 | 2019 | 7721 | 0.080 |
Why?
|
| Norepinephrine | 1 | 2010 | 909 | 0.080 |
Why?
|
| Dopamine Plasma Membrane Transport Proteins | 1 | 2010 | 422 | 0.080 |
Why?
|
| Dopamine and cAMP-Regulated Phosphoprotein 32 | 1 | 2006 | 31 | 0.070 |
Why?
|
| Genotype | 1 | 2021 | 12952 | 0.070 |
Why?
|
| Gene Expression Regulation | 2 | 2017 | 12073 | 0.070 |
Why?
|
| Aminopyridines | 1 | 2010 | 542 | 0.070 |
Why?
|
| Neuralgia | 1 | 2013 | 570 | 0.070 |
Why?
|
| Cerebral Cortex | 3 | 2017 | 5709 | 0.070 |
Why?
|
| Protein Binding | 4 | 2012 | 9384 | 0.070 |
Why?
|
| Nucleus Accumbens | 3 | 2006 | 366 | 0.070 |
Why?
|
| Serotonin | 1 | 2010 | 1017 | 0.070 |
Why?
|
| Cognition Disorders | 2 | 2021 | 4043 | 0.070 |
Why?
|
| Random Allocation | 1 | 2010 | 2428 | 0.060 |
Why?
|
| Hypothalamus | 1 | 2010 | 1063 | 0.060 |
Why?
|
| Nortriptyline | 1 | 2004 | 81 | 0.060 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2010 | 1375 | 0.060 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 1 | 2006 | 491 | 0.060 |
Why?
|
| Bromodeoxyuridine | 1 | 2004 | 322 | 0.060 |
Why?
|
| Corpus Striatum | 1 | 2010 | 1221 | 0.060 |
Why?
|
| Recreation | 1 | 2004 | 115 | 0.060 |
Why?
|
| Lithium | 1 | 2007 | 601 | 0.060 |
Why?
|
| Immunotherapy | 2 | 2021 | 4446 | 0.060 |
Why?
|
| Mice, Inbred ICR | 2 | 2003 | 352 | 0.060 |
Why?
|
| Calmodulin-Binding Proteins | 1 | 2005 | 250 | 0.060 |
Why?
|
| Antiparkinson Agents | 2 | 2018 | 184 | 0.060 |
Why?
|
| Parkinson Disease | 1 | 2017 | 2775 | 0.060 |
Why?
|
| Asphyxia | 1 | 2003 | 57 | 0.060 |
Why?
|
| Pain Measurement | 3 | 2003 | 3420 | 0.060 |
Why?
|
| Antimanic Agents | 1 | 2007 | 522 | 0.060 |
Why?
|
| Binding, Competitive | 3 | 2011 | 1157 | 0.060 |
Why?
|
| Models, Biological | 1 | 2019 | 9584 | 0.060 |
Why?
|
| Neurons, Efferent | 1 | 2003 | 82 | 0.060 |
Why?
|
| Neuronal Plasticity | 2 | 2015 | 1423 | 0.050 |
Why?
|
| Area Postrema | 1 | 2021 | 7 | 0.050 |
Why?
|
| Electrical Synapses | 1 | 2022 | 19 | 0.050 |
Why?
|
| Oncogene Protein v-akt | 1 | 2022 | 135 | 0.050 |
Why?
|
| Hypertension | 1 | 2022 | 8479 | 0.050 |
Why?
|
| Microsomes, Liver | 2 | 2012 | 173 | 0.050 |
Why?
|
| Drug Design | 1 | 2007 | 1076 | 0.050 |
Why?
|
| Circadian Rhythm | 2 | 2011 | 2624 | 0.050 |
Why?
|
| Gliosis | 2 | 2017 | 245 | 0.050 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2009 | 1222 | 0.050 |
Why?
|
| Arousal | 2 | 2000 | 1164 | 0.050 |
Why?
|
| Data Interpretation, Statistical | 1 | 2011 | 2716 | 0.050 |
Why?
|
| Gambling | 1 | 2004 | 250 | 0.050 |
Why?
|
| Genetics, Behavioral | 1 | 2000 | 53 | 0.050 |
Why?
|
| Neuropeptides | 1 | 2006 | 942 | 0.050 |
Why?
|
| Synaptic Vesicles | 1 | 2002 | 191 | 0.050 |
Why?
|
| Hybridization, Genetic | 1 | 2000 | 109 | 0.050 |
Why?
|
| Nerve Tissue Proteins | 2 | 2005 | 4463 | 0.050 |
Why?
|
| Cell Count | 1 | 2004 | 1856 | 0.050 |
Why?
|
| Female | 20 | 2023 | 380193 | 0.040 |
Why?
|
| Drug Administration Schedule | 1 | 2008 | 4933 | 0.040 |
Why?
|
| Prefrontal Cortex | 1 | 2010 | 2147 | 0.040 |
Why?
|
| Sex Factors | 3 | 2019 | 10400 | 0.040 |
Why?
|
| Drug Interactions | 1 | 2004 | 1460 | 0.040 |
Why?
|
| Cytoskeleton | 1 | 2005 | 1185 | 0.040 |
Why?
|
| Habituation, Psychophysiologic | 1 | 2000 | 154 | 0.040 |
Why?
|
| Carbon Dioxide | 1 | 2003 | 1150 | 0.040 |
Why?
|
| Conditioning, Operant | 1 | 2000 | 313 | 0.040 |
Why?
|
| Mice, Inbred DBA | 1 | 2019 | 642 | 0.040 |
Why?
|
| Mice, Inbred Strains | 2 | 2000 | 1828 | 0.040 |
Why?
|
| Exploratory Behavior | 2 | 2015 | 270 | 0.040 |
Why?
|
| Neurotransmitter Agents | 1 | 2002 | 647 | 0.040 |
Why?
|
| Adrenergic beta-1 Receptor Agonists | 1 | 2017 | 15 | 0.040 |
Why?
|
| Receptor, Serotonin, 5-HT2B | 1 | 2017 | 6 | 0.040 |
Why?
|
| Levodopa | 1 | 2018 | 219 | 0.040 |
Why?
|
| Urinary Bladder, Overactive | 1 | 2019 | 106 | 0.040 |
Why?
|
| Self Administration | 2 | 2010 | 385 | 0.040 |
Why?
|
| Memory Disorders | 1 | 2005 | 1186 | 0.040 |
Why?
|
| Cocaine-Related Disorders | 1 | 2001 | 460 | 0.040 |
Why?
|
| Protons | 1 | 2023 | 1127 | 0.040 |
Why?
|
| Endocytosis | 1 | 2002 | 985 | 0.040 |
Why?
|
| Hyperkinesis | 1 | 2017 | 89 | 0.040 |
Why?
|
| Actins | 1 | 2005 | 2121 | 0.040 |
Why?
|
| Lod Score | 1 | 1997 | 614 | 0.040 |
Why?
|
| Signal Transduction | 5 | 2022 | 23404 | 0.040 |
Why?
|
| Thalamus | 1 | 2003 | 1023 | 0.040 |
Why?
|
| Behavior | 1 | 2000 | 561 | 0.040 |
Why?
|
| Synapses | 2 | 2017 | 1728 | 0.040 |
Why?
|
| Humans | 22 | 2023 | 744366 | 0.040 |
Why?
|
| Albuterol | 1 | 2017 | 208 | 0.040 |
Why?
|
| Blood Proteins | 2 | 2012 | 1124 | 0.040 |
Why?
|
| Norway | 1 | 2017 | 448 | 0.030 |
Why?
|
| Mice, Inbred C3H | 1 | 1997 | 964 | 0.030 |
Why?
|
| Molecular Biology | 1 | 2000 | 596 | 0.030 |
Why?
|
| Phagocytosis | 1 | 2022 | 1539 | 0.030 |
Why?
|
| Protein Conformation | 2 | 2018 | 4010 | 0.030 |
Why?
|
| gamma-Aminobutyric Acid | 1 | 2022 | 1121 | 0.030 |
Why?
|
| Synapsins | 1 | 2015 | 43 | 0.030 |
Why?
|
| Propranolol | 1 | 2017 | 502 | 0.030 |
Why?
|
| Substantia Nigra | 1 | 2017 | 353 | 0.030 |
Why?
|
| Dyspnea | 1 | 2003 | 1303 | 0.030 |
Why?
|
| Synaptophysin | 1 | 2015 | 141 | 0.030 |
Why?
|
| Administration, Oral | 1 | 2003 | 3914 | 0.030 |
Why?
|
| HEK293 Cells | 2 | 2017 | 4208 | 0.030 |
Why?
|
| Solubility | 1 | 2017 | 1088 | 0.030 |
Why?
|
| Morphine Dependence | 1 | 1995 | 31 | 0.030 |
Why?
|
| Membrane Glycoproteins | 1 | 2006 | 3771 | 0.030 |
Why?
|
| Phosphopyruvate Hydratase | 1 | 2015 | 135 | 0.030 |
Why?
|
| Immobilization | 1 | 1996 | 236 | 0.030 |
Why?
|
| Drosophila Proteins | 1 | 2004 | 1703 | 0.030 |
Why?
|
| Neurogenesis | 1 | 2022 | 838 | 0.030 |
Why?
|
| Quinolizines | 1 | 2014 | 19 | 0.030 |
Why?
|
| Azocines | 1 | 2014 | 18 | 0.030 |
Why?
|
| Disease Susceptibility | 1 | 2022 | 1782 | 0.030 |
Why?
|
| Eating | 1 | 2021 | 1536 | 0.030 |
Why?
|
| Reaction Time | 3 | 2001 | 2098 | 0.030 |
Why?
|
| Phenotype | 3 | 2021 | 16367 | 0.030 |
Why?
|
| Acetylation | 1 | 2017 | 1084 | 0.030 |
Why?
|
| Quantitative Trait, Heritable | 1 | 1997 | 544 | 0.030 |
Why?
|
| Chromosomes | 1 | 1997 | 596 | 0.030 |
Why?
|
| Excitatory Postsynaptic Potentials | 1 | 2015 | 377 | 0.030 |
Why?
|
| Learning | 2 | 2019 | 1711 | 0.030 |
Why?
|
| Gene Deletion | 1 | 2021 | 2751 | 0.030 |
Why?
|
| Alkaloids | 1 | 2014 | 190 | 0.030 |
Why?
|
| Anilides | 1 | 2016 | 408 | 0.030 |
Why?
|
| Carbon Monoxide | 1 | 1996 | 531 | 0.030 |
Why?
|
| Desipramine | 1 | 2013 | 184 | 0.030 |
Why?
|
| Urinary Bladder | 1 | 2019 | 1173 | 0.030 |
Why?
|
| Temperature | 1 | 2019 | 2204 | 0.030 |
Why?
|
| Calcium-Binding Proteins | 1 | 2017 | 1081 | 0.030 |
Why?
|
| Ether-A-Go-Go Potassium Channels | 1 | 2012 | 70 | 0.030 |
Why?
|
| Microfilament Proteins | 1 | 2017 | 1152 | 0.030 |
Why?
|
| Cell Line | 3 | 2012 | 16000 | 0.030 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2020 | 1988 | 0.030 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 2017 | 1240 | 0.030 |
Why?
|
| Receptors, Neurotransmitter | 1 | 2011 | 178 | 0.020 |
Why?
|
| Neural Pathways | 1 | 2002 | 2974 | 0.020 |
Why?
|
| Protein Isoforms | 2 | 2009 | 1730 | 0.020 |
Why?
|
| Genetic Markers | 1 | 1997 | 2634 | 0.020 |
Why?
|
| Health Status | 1 | 2004 | 4034 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 2004 | 11366 | 0.020 |
Why?
|
| Enhancer Elements, Genetic | 1 | 2017 | 1340 | 0.020 |
Why?
|
| Neuroprotective Agents | 1 | 2017 | 941 | 0.020 |
Why?
|
| Molecular Conformation | 1 | 2012 | 562 | 0.020 |
Why?
|
| Energy Metabolism | 1 | 2022 | 2897 | 0.020 |
Why?
|
| High-Throughput Screening Assays | 1 | 2016 | 944 | 0.020 |
Why?
|
| Light | 1 | 2016 | 1374 | 0.020 |
Why?
|
| Lipopolysaccharides | 1 | 2017 | 2216 | 0.020 |
Why?
|
| Memory | 2 | 2014 | 2174 | 0.020 |
Why?
|
| Astrocytes | 1 | 2017 | 1273 | 0.020 |
Why?
|
| DNA | 1 | 2023 | 7294 | 0.020 |
Why?
|
| Mutation, Missense | 1 | 2018 | 2566 | 0.020 |
Why?
|
| Endothelial Cells | 1 | 2022 | 3486 | 0.020 |
Why?
|
| Monoamine Oxidase Inhibitors | 1 | 2009 | 158 | 0.020 |
Why?
|
| Treatment Failure | 1 | 2014 | 2618 | 0.020 |
Why?
|
| Adaptation, Physiological | 1 | 2015 | 1312 | 0.020 |
Why?
|
| Cricetulus | 1 | 2010 | 818 | 0.020 |
Why?
|
| Discrimination Learning | 1 | 2010 | 280 | 0.020 |
Why?
|
| Prosencephalon | 1 | 2010 | 303 | 0.020 |
Why?
|
| Age Factors | 3 | 2015 | 18373 | 0.020 |
Why?
|
| Dyskinesia, Drug-Induced | 1 | 2009 | 163 | 0.020 |
Why?
|
| Gene Expression | 1 | 2021 | 7798 | 0.020 |
Why?
|
| Receptors, Opioid, mu | 1 | 2009 | 182 | 0.020 |
Why?
|
| Immunoglobulin G | 1 | 2020 | 4561 | 0.020 |
Why?
|
| Chlordiazepoxide | 1 | 2007 | 42 | 0.020 |
Why?
|
| Histones | 1 | 2017 | 2598 | 0.020 |
Why?
|
| Crystallography, X-Ray | 1 | 2012 | 2012 | 0.020 |
Why?
|
| Antigens, CD | 1 | 2017 | 4026 | 0.020 |
Why?
|
| Cricetinae | 1 | 2010 | 2475 | 0.020 |
Why?
|
| Receptors, Dopamine D2 | 1 | 2009 | 475 | 0.020 |
Why?
|
| Mood Disorders | 1 | 2013 | 1106 | 0.020 |
Why?
|
| Excitatory Amino Acid Agonists | 1 | 2006 | 146 | 0.020 |
Why?
|
| Amphetamine | 1 | 2007 | 225 | 0.020 |
Why?
|
| Promoter Regions, Genetic | 1 | 2017 | 5867 | 0.020 |
Why?
|
| Piperazines | 1 | 2016 | 2488 | 0.020 |
Why?
|
| Mice, Neurologic Mutants | 1 | 2005 | 126 | 0.020 |
Why?
|
| Risk | 1 | 2017 | 9688 | 0.020 |
Why?
|
| Receptors, AMPA | 1 | 2006 | 332 | 0.020 |
Why?
|
| Genetic Variation | 1 | 2000 | 6542 | 0.020 |
Why?
|
| Analgesics, Opioid | 1 | 2001 | 3677 | 0.020 |
Why?
|
| Bankruptcy | 1 | 2004 | 27 | 0.020 |
Why?
|
| Pimozide | 1 | 2004 | 21 | 0.020 |
Why?
|
| Patch-Clamp Techniques | 1 | 2006 | 964 | 0.010 |
Why?
|
| Social Environment | 2 | 2000 | 1022 | 0.010 |
Why?
|
| Cotinine | 1 | 2004 | 206 | 0.010 |
Why?
|
| Membrane Potentials | 1 | 2006 | 1137 | 0.010 |
Why?
|
| Tetracycline | 1 | 2003 | 214 | 0.010 |
Why?
|
| Molecular Targeted Therapy | 1 | 2014 | 2725 | 0.010 |
Why?
|
| Mutation | 2 | 2023 | 29786 | 0.010 |
Why?
|
| Pentylenetetrazole | 1 | 2002 | 69 | 0.010 |
Why?
|
| Cytokines | 1 | 2017 | 7323 | 0.010 |
Why?
|
| Reward | 1 | 2009 | 940 | 0.010 |
Why?
|
| Stress, Psychological | 1 | 1997 | 4245 | 0.010 |
Why?
|
| Dendrites | 1 | 2005 | 485 | 0.010 |
Why?
|
| Pyridinium Compounds | 1 | 2002 | 83 | 0.010 |
Why?
|
| GABA Antagonists | 1 | 2002 | 128 | 0.010 |
Why?
|
| 3,4-Dihydroxyphenylacetic Acid | 1 | 2001 | 64 | 0.010 |
Why?
|
| Cholinergic Fibers | 1 | 2001 | 68 | 0.010 |
Why?
|
| Quaternary Ammonium Compounds | 1 | 2002 | 205 | 0.010 |
Why?
|
| Estrus | 1 | 2001 | 81 | 0.010 |
Why?
|
| Prisoners | 1 | 2004 | 297 | 0.010 |
Why?
|
| Presynaptic Terminals | 1 | 2003 | 302 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2017 | 16690 | 0.010 |
Why?
|
| Clathrin | 1 | 2002 | 267 | 0.010 |
Why?
|
| Inflammation | 1 | 2019 | 10637 | 0.010 |
Why?
|
| Transgenes | 1 | 2003 | 1009 | 0.010 |
Why?
|
| Acetylcholine | 1 | 2001 | 621 | 0.010 |
Why?
|
| Blotting, Western | 1 | 2006 | 5181 | 0.010 |
Why?
|
| Gyrus Cinguli | 1 | 2005 | 1091 | 0.010 |
Why?
|
| Electrophysiology | 1 | 2001 | 1308 | 0.010 |
Why?
|
| Age Distribution | 1 | 2004 | 2902 | 0.010 |
Why?
|
| Aged | 3 | 2021 | 163288 | 0.010 |
Why?
|
| Age of Onset | 1 | 2004 | 3270 | 0.010 |
Why?
|
| Interviews as Topic | 1 | 2004 | 2539 | 0.010 |
Why?
|
| Cell Division | 1 | 2004 | 4569 | 0.010 |
Why?
|
| Glutamic Acid | 1 | 2002 | 1169 | 0.010 |
Why?
|
| Cell Survival | 1 | 2006 | 5882 | 0.010 |
Why?
|
| Point Mutation | 1 | 2001 | 1624 | 0.010 |
Why?
|
| Species Specificity | 1 | 2000 | 2478 | 0.010 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2006 | 2917 | 0.010 |
Why?
|
| Calcium | 1 | 2009 | 5755 | 0.010 |
Why?
|
| Phosphorylation | 1 | 2006 | 8436 | 0.010 |
Why?
|
| Motivation | 1 | 2004 | 1971 | 0.010 |
Why?
|
| Opioid-Related Disorders | 1 | 2009 | 2064 | 0.010 |
Why?
|
| Fluorescent Dyes | 1 | 2002 | 1917 | 0.010 |
Why?
|
| Alcoholism | 1 | 2004 | 1906 | 0.010 |
Why?
|
| Estrogens | 1 | 2001 | 1566 | 0.010 |
Why?
|
| Extinction, Psychological | 1 | 1996 | 376 | 0.010 |
Why?
|
| Naloxone | 1 | 1995 | 367 | 0.010 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2003 | 3617 | 0.010 |
Why?
|
| Models, Neurological | 1 | 2000 | 1775 | 0.010 |
Why?
|
| Adolescent | 2 | 2013 | 85779 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 2005 | 13035 | 0.010 |
Why?
|
| Apoptosis | 1 | 2004 | 9724 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2013 | 57776 | 0.000 |
Why?
|
| Survival Rate | 1 | 2002 | 12788 | 0.000 |
Why?
|
| Young Adult | 1 | 2013 | 56429 | 0.000 |
Why?
|
| Middle Aged | 2 | 2013 | 213390 | 0.000 |
Why?
|
| Adult | 2 | 2013 | 214052 | 0.000 |
Why?
|
| Cross-Sectional Studies | 1 | 2004 | 25039 | 0.000 |
Why?
|